Vol. XXII: April 1, 2019 – May 31, 2019
The OIG has identified areas of significant concern that cause the Department to be at particular risk of fraud, mismanagement, waste,
deficiencies, or abuse.
Our latest Semiannual Report to Congress for the period ending March 31, 2019
OWCP Must Continue Strengthening Management of FECA Pharmaceuticals, Including Opioids
The Audit Workplan describes the OIG's current and planned audits for FY 2019.
Contact OIG Hotline
OIG PUBLICATIONS & REPORTS